Celgene's CEO Wants to Make the Biotech's Best-Selling Drug Obsolete — Here's Why That's Great for Investors by admin • 7 September, 2018 Revlimid is Celgene's biggest moneymaker by far. But here's how and why CEO Mark Alles wants to make it disappear.
Revlimid is Celgene's biggest moneymaker by far. But here's how and why CEO Mark Alles wants to make it disappear.